108124-66-9

Basic information

• Product Name: ETHYL 4-(2-METHOXY-5-METHYLPHENYL)-4-OXOBUTANOATE
• Synonyms: ETHYL 4-(2-METHOXY-5-METHYLPHENYL)-4-OXOBUTANOATE
• CAS NO: 108124-66-9
• Molecular Formula: C₁₄H₁₈O₄
• Molecular Weight: 250.3
• Mol File: 108124-66-9.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 380.6°C at 760 mmHg
• Flash Point: 167.7°C
• Appearance: /
• Density: 1.084g/cm³
• Vapor Pressure: 5.37E-06mmHg at 25°C
• Refractive Index: 1.501
• CAS DataBase Reference: ETHYL 4-(2-METHOXY-5-METHYLPHENYL)-4-OXOBUTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4-(2-METHOXY-5-METHYLPHENYL)-4-OXOBUTANOATE(108124-66-9)
• EPA Substance Registry System: ETHYL 4-(2-METHOXY-5-METHYLPHENYL)-4-OXOBUTANOATE(108124-66-9)

Safety Data

• Hazardous Substances Data: 108124-66-9(Hazardous Substances Data)

Usage

InChI:InChI=1/C14H18O4/c1-4-18-14(16)8-6-12(15)11-9-10(2)5-7-13(11)17-3/h5,7,9H,4,6,8H2,1-3H3

Upstream product

• 104-93-8 p-methylanizole 
• 75-09-2 dichloromethane 
• 14794-31-1 ethyl 3-(chloroformyl)propionate 

Downstream Products

• 55007-22-2 methyl 4-(2-hydroxymethyl-5-ethylphenyl)-4-carbonylbutanoate 

Relevant articles and documents

TETRAHYDRO-6,7-DIMETHOXY-1H-BENZ[E]ISOINODOLINES USEFUL IN THE TREATMENT OF HYPERTENSION AND AS SEDATIVES

Disclosed herein are tetrahydro-benzo e!isoindolines represented by the formula STR1 wherein R, R 1 and R 2 are independently selected from hydrogen, loweralkyl of 1 to 4 carbon atoms, hydroxy, loweralkoxy of 1 to 3 carbon atoms, allyloxy, benzyloxy, benzoyloxy, thiomethyl, halo, STR2 wherein t is 0 or 1, n is 0 to 5 and R 11 and R 14 are independently selected from hydrogen, halo, hydroxy, loweralkyl of 1 to 4 carbon atoms, loweralkoxy of 1 to 3 carbon atoms or amino; orR and R. sub.1, or R 1 and R 2 can be taken together to form a methylenedioxy or ethylenedioxy bridge; with the proviso that at least one of R, R 1 or R 2 must be other than hydrogen and the proviso that two of R, R 1, or R 2 must be other than methoxy in the 7 and 8 positions when the remaining one of R, R 1 or R 2 is hydrogen; andR 3 is hydrogen, loweralkyl of 1 to 4 carbon atoms, halo-substituted loweralkyl of 1 to 4 carbon atoms, amino-substituted loweralkyl of 1 to 4 carbon atoms, amino-substituted arylalkyl, allyl, thioloweralkyl, loweralkanol, or STR3 wherein R 12 and R 13 are independently selected from hydrogen, hydroxy, amino, loweralkoxy of 1 to 3 carbon atoms and s is 1 to 3; or STR4 wherein m is 0, 1 or 2, p is 0 or 1, R 7 is hydrogen or loweralkyl of 1 to 4 carbon atoms and R 8 and R 9 are independently selected from hydrogen, hydroxy, methoxy, loweralkyl of 1 to 4 carbon atoms, or halo, or R 8 and R 9 can be taken together to form a methylenedioxy or ethylenedioxy bridge; or 1,4-benzodioxan of the formula STR5 wherein q is 1, 2 or 3, and R 10 is hydrogen, methoxy, amino, or halo; and the pharmaceutically acceptable salts thereof.